Trial
NCT06501911
A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
—
Condition
Recurrent Glioblastoma
Intervention
Bicalutamide
Why stopped
PI leaving institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-22